An Exceptionally Rare Case of Acute Prostatitis Caused by Myroides odoratimimus Infection
Abstract
Myroides odoratimimus (M. odoratimimus) is a rare, multidrug-resistant bacterium that occasionally causes opportunistic infections in the environment. We report the first documented case of acute prostatitis caused by M. odoratimimus in a 95-year-old man following transurethral water vapor energy therapy for benign prostatic hyperplasia. The patient developed fever and prostatic tenderness postoperatively, with CT findings consistent with prostatitis. The initial empirical treatment with piperacillin/tazobactam was ineffective. Urine culture revealed a multidrug-resistant bacterium susceptible only to minocycline, which was identified as M. odoratimimus by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and 16S rRNA sequencing. Treatment with minocycline led to clinical improvement. This case underscores the importance of considering rare pathogens in patients with indwelling catheters or postoperative infections, particularly when standard antimicrobial therapies prove ineffective. Accurate microbiological diagnosis and appropriate treatment based on antimicrobial susceptibility testing are essential in managing such infections.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.